Samsara BioCapital raises $310 mln for venture-capital fund

Samsara BioCapital has raised $310 million for a venture-capital fund, according to a filing with the SEC.

Fifty-seven LPs contributed capital. The fund’s partners include former Sofinnova Ventures General Partner Srini Akkaraju and Michael Dybbs, a former partner at New Leaf Venture Partners. Akkaraju also worked at New Leaf.

The filing is available here.